The analysis revealed that UPF3B expression was higher in 13 tumors, including Bladder Urothelial Carcinoma (BLCA), Breast Invasive Carcinoma (BRCA), Squamous cell carcinoma of the cervix (CESC), Cholangiocarcinoma (CHOL), Head and Neck Squamous Cell Carcinoma (HNSC), ESCA, Colon Adenocarcinoma (COAD), LIHC, Lung Adenocarcinoma (LUAD), Lung Squamous Cell Carcinoma (LUSC), Paraganglioma (PCPG) and Pheochromocytoma, Rectum Adenocarcinoma (READ), Stomach Adenocarcinoma (STAD). Here, UPF3B is linked to colon adenocarcinoma.